Antitumor activity of pemetrexed (Pem) in second-line advanced/metastatic osteosarcomas: A multicenter phase II study

Autor:	Alessandro Comandone, N. Bin Bui, Hisham Rassam, Florence Duffaud, S. Weitckus, Angela Cioffi, S. Ameryckx, A. Michel, Gerlinde Egerer, Silvia Ferrari
Rok vydání:	2010
Předmět:	Antitumor activity Oncology Malignant bone tumor Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Phases of clinical research medicine.disease Second line Pemetrexed Internal medicine medicine Osteosarcoma Young adult business medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:10076-10076
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.10076
Popis:	10076 Background: Osteosarcoma (OS) is the most common primary malignant bone tumor in young adults. Despite improved prognosis, resistance to chemotherapy remains responsible for failure of OS tre...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::75416cae53a085d34e124ec560f30409 https://doi.org/10.1200/jco.2010.28.15_suppl.10076 Zobrazit plný text záznamu